Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmaco...(is leveraging its fully integrated drug ...)

Date:4/10/2008

is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic alliances with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Organon, Schering-Plough, and Wyeth Pharmaceuticals. For more information please visit the company's website at http://www.pharmacopeia.com.

Contact:

Brian M. Posner

Executive Vice President and Chief Financial Officer

609-452-3635

ir_pr@pharmacopeia.com

This press release, and oral statements made with respect to information contained in this press release, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those which express plan, anticipation, intent, goal, contingency or future development and/or otherwise are not statements of historical fact. These statements are based upon management's current expectations and are subject to risks and uncertainties, known and unknown, which could cause actual results and developments to differ materially from those expressed or implied in such statements. These forward- looking statements include, but are not limited to, statements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its DARA program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmacopeia's plans to develop PS178990, a product candidate from its SARM program, Pharmacopeia's Phase 1 clinical studies with respect to PS178990, including timing and expected outcomes of such studies, Pharmacopeia's plans to develop PS031291, a product candidate from its chemokine recepto
'/>"/>

SOURCE Pharmacopeia, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Helix BioPharma Chairman resigns
2. Indivumed Appoints Annette Kassen as Vice President Clinical Research
3. ADVENTRX Appoints Vice President of Manufacturing
4. Cylex Announces Brad L. Stewart as President of the Company
5. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
6. Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer
7. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
8. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
9. Thomas W. Burke, MD, Elected 40th President of the Society of Gynecologic Oncologists
10. Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer
11. Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology